NDC 64764-516 - VONVENDI
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 64764-516
- Package NDCs from labels
- 64764-516-10
- Manufacturer
- Takeda Pharmaceuticals America, Inc. | Baxalta US Inc. | Siegfried Hameln GmbH | Baxalta Manufacturing Sàrl
- Effective date
- 2026-07-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| VONVENDI | Takeda Pharmaceuticals America, Inc. | Baxalta US Inc. | Siegfried Hameln GmbH | Baxalta Manufacturing Sàrl | 2026-07-28 | PLASMA DERIVATIVE |
| CEPROTIN - Takeda Pharmaceuticals America, Inc. | Takeda Manufacturing Austria AG | Siegfried Hameln GmbH | Takeda Pharmaceuticals America, Inc. | Takeda Manufacturing Austria AG | Siegfried Hameln GmbH | 2025-12-04 | PLASMA DERIVATIVE |
| FEIBA - Takeda Pharmaceuticals America, Inc. | Takeda Manufacturing Austria AG | Siegfried Hameln GmbH | Takeda Pharmaceuticals America, Inc. | Takeda Manufacturing Austria AG | Siegfried Hameln GmbH | 2025-11-27 | HUMAN PRESCRIPTION DRUG LABEL |
| HEMOFIL M - Takeda Pharmaceuticals America, Inc. | BAXALTA US Inc. | Takeda Pharmaceuticals America, Inc. | BAXALTA US Inc. | 2025-03-06 | PLASMA DERIVATIVE |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 64764-516 | FEIBA (ANTI-INHIBITOR COAGULANT COMPLEX) KIT [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 29 | Unmatched | 20250109_752604e5-4ea2-44f4-83ed-1569373f6412.zip |
| 64764-516 | VONVENDI (VON WILLEBRAND FACTOR (RECOMBINANT)) KIT [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 17 | Unmatched | 20230418_53b6d198-6175-4a26-8606-dc0d2a0f12d6.zip |
| 64764-516 | HEMOFIL M (ANTIHEMOPHILIC FACTOR HUMAN) KIT [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 15 | Unmatched | 20250309_b8953ff7-3bba-4a0b-a486-f26fb81f05d9.zip |
| 64764-516 | CEPROTIN (PROTEIN C CONCENTRATE HUMAN) KIT [TAKEDA PHARMACEUTICALS AMERICA, INC.] | 14 | Unmatched | 20250110_926914a9-78b2-40ea-b37d-2a55c09bf275.zip |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| STERILE WATER | STERILE WATER | HF Acquisition Co LLC, DBA HealthFirst | 77bd3c0f-f4ab-7cfa-e053-2a91aa0a1b83 | 2025-01-09 | Warnings, Adverse reactions | 059QF0KO0R |
| STERILE WATER | STERILE WATER | HF Acquisition Co LLC, DBA HealthFirst | 7610bf80-61b7-982f-e053-2a91aa0ac1bb | 2025-01-09 | Warnings, Adverse reactions | 059QF0KO0R |
| A-36 | BOS TAURUS ADRENAL GLAND, AGRIMONIA EUPATORIA, BELLIS PERENNIS, CAMPHOR (NATURAL), MATRICARIA CHAMOMILLA, EQUISETUM HYEMALE, FRAXINUS AMERICANA BARK, FORMICA RUFA, HISTAMINE DIHYDROCHLORIDE, IODINE, POTASSIUM DICHROMATE, CANIS LUPUS FAMILIARIS MILK, SODIUM CHLORIDE, ANEMONE PULSATILLA, SALIX NIGRA BARK, AND TOBACCO LEAF | DNA Labs, Inc. | 161c4738-9ead-4687-9f5a-029d5a496e07 | 2025-01-09 | Warnings | 451W47IQ8X |
| AM-11 | ARNICA MONTANA, SODIUM CHLORIDE, AND APIS MELLIFERA | DNA Labs, Inc. | c072811b-6259-4b22-b364-50369dc68fb0 | 2025-01-09 | Warnings | 451W47IQ8X |
| N-13 | CEANOTHUS AMERICANUS LEAF, URTICA URENS, SODIUM CHLORIDE, LACHESIS MUTA WHOLE, CINCHONA OFFICINALIS BARK, LYCOPODIUM CLAVATUM WHOLE, FERRIC CHLORIDE HEXAHYDRATE, AND SUS SCROFA SPLEEN | DNA Labs, Inc. | 146c5465-bcd9-4057-8975-dc1088b9971b | 2025-01-09 | Warnings | 451W47IQ8X |
| N-10 | SODIUM CHLORIDE, OYSTER SHELL CALCIUM CARBONATE, CRUDE, SEPIA OFFICINALIS JUICE, IODINE, LYCOPODIUM CLAVATUM WHOLE, AND BOS TAURUS PITUITARY GLAND, POSTERIOR | DNA Labs, Inc. | 264d8093-70f3-43a5-bfc4-b719bb3e45e6 | 2025-01-09 | Warnings | 451W47IQ8X |
| N-16 | MGO ENERGIZER | DNA Labs, Inc. | 8292b900-86c1-47ea-81da-b587439c7664 | 2025-01-09 | Warnings | 451W47IQ8X TE7660XO1C |
| N-21 | CALCIUM FLUORIDE, SILICON DIOXIDE, EUPHRASIA STRICTA, RUTA GRAVEOLENS WHOLE, GELSEMIUM SEMPERVIRENS WHOLE, PHYSOSTIGMA VENENOSUM WHOLE, ANEMONE PULSATILLA, SODIUM CHLORIDE, AND SUS SCROFA EYE | DNA Labs, Inc. | 89967941-c4ee-4598-a66d-8a93d69a4d65 | 2025-01-09 | Warnings | 451W47IQ8X |
| N-14 | FUCUS VESICULOSUS, SODIUM CHLORIDE, LYCOPUS VIRGINICUS, SPONGIA OFFICINALIS SKELETON, ROASTED, POTASSIUM IODIDE, CALCIUM IODIDE, THYROID, UNSPECIFIED, BOS TAURUS ADRENAL GLAND, BOS TAURUS PITUITARY GLAND, POSTERIOR, BOS TAURUS THYMUS, AND SUS SCROFA SPLEEN | DNA Labs, Inc. | 3d64739c-5d61-4e88-8612-d5f6994f1c3c | 2025-01-09 | Warnings | 451W47IQ8X |
| N-24 | METABOLIN | DNA Labs, Inc. | 559fca2b-1093-4bdf-be70-c453f87002c3 | 2025-01-09 | Warnings | 451W47IQ8X |
| T-27 | WATER | DNA Labs, Inc. | f0e9afd7-64a4-4b85-9c5f-4bf07ba4b481 | 2025-01-09 | Warnings | 059QF0KO0R |
| GAVILAX | POLYETHYLENE GLYCOL 3350 | A-S Medication Solutions | 581baa4b-7331-47a3-81c6-680286f03aca | 2025-01-09 | Warnings | G2M7P15E5P |
| Sterile Water | STERILE WATER FOR INJECTION | Medefil, Inc. | 99e99a50-82d5-aff6-e053-2a95a90a8c56 | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| BACTERIOSTATIC WATER | BACTERIOSTATIC WATER | HF Acquisition Co LLC, DBA HealthFirst | 99b0ef9b-600a-40dc-e053-2a95a90aa07e | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| 0.9% SODIUM CHLORIDE | 0.9% SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 8dfb05c0-77e8-2fa1-e053-2a95a90a3d33 | 2025-01-08 | Adverse reactions | 451W47IQ8X |
| STERILE WATER | STERILE WATER | HF Acquisition Co LLC, DBA HealthFirst | 99b1cb12-0b2d-0c0f-e053-2a95a90ac3b6 | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| SODIUM CHLORIDE | SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 998a2a47-5c79-2efd-e053-2995a90a8fac | 2025-01-08 | Adverse reactions | 451W47IQ8X |
| SODIUM CHLORIDE | SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 7da788fc-3481-527f-e053-2a91aa0af6ac | 2025-01-08 | Adverse reactions | 451W47IQ8X |
| Emetrol Powder Non-Drowsy | SODIUM CITRATE DIHYDRATE | WellSpring Pharmaceutical Corporation | 9d8d2ee7-9db7-4be7-8c73-511eb2e32459 | 2025-01-08 | Warnings | B22547B95K |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | BECTON DICKINSON AND COMPANY | c1d0f42e-3494-4217-8f86-e9f34d930e82 | 2025-01-07 | Warnings, Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.